Showing results (91-100 of 514) with videos related to

Sort By:
Pageof 52
International Journal of Molecular Medicine|April 5, 2005
Inactivation of Ets 1 transcription factor by a specific decoy strategy reduces rat C6 glioma cell proliferation and mmp-9 expressionAyguen Sahin, Markus Velten, Torsten Pietsch, et al.
Anticancer Research|September 16, 2016
Assessment of Promoter Methylation Identifies PTCH as a Putative Tumor-suppressor Gene in Human CLLIngo G H Schmidt-Wolf, Christoph Plass, John C Byrd, et al.
International Journal of Oncology|December 25, 2010
Differential forms of p53 in medulloblastoma primary tumors, cell lines and xenograftsTzvetomira Philipova, Ninib Baryawno, Wolfgang Hartmann, et al.
Pediatric Research|November 23, 2019
Musashi1 enhances chemotherapy resistance of pediatric glioblastoma cells in vitroRebecca Pötschke, Gerrit Gielen, Torsten Pietsch, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|September 10, 2002
Demonstration of human herpesvirus 8 in a case of primary vaginal epithelioid angiosarcoma by in situ hybridization, electron microscopy, and polymerase chain reactionMarco Gessi, Paola Cattani, Nicola Maggiano, et al.
Journal of Cellular and Molecular Medicine|January 30, 2018
The FDA approved PI3K inhibitor GDC-0941 enhances in vitro the anti-neoplastic efficacy of Axitinib against c-myc-amplified high-risk medulloblastomaMichael Ehrhardt, Rogerio B Craveiro, Julia Velz, et al.
Pediatric Blood & Cancer|February 11, 2005
Cervico-medullary desmoplastic infantile ganglioglioma: an unusual case with diffuse leptomeningeal dissemination at diagnosisClaudia Milanaccio, Paolo Nozza, Marcello Ravegnani, et al.
Journal of Neuro-Oncology|October 7, 2009
Clinical and epidemiological characteristics of pediatric gliosarcomasMichael Karremann, Ulrike Rausche, Gudrun Fleischhack, et al.
Pediatric Blood & Cancer|March 22, 2006
Cerebellar medullomyoblastoma with melanotic tubular structuresPaolo Nozza, Claudia Milanaccio, Gianluca Piatelli, et al.
Frontiers in Oncology|December 10, 2021
Defining the Spectrum, Treatment and Outcome of Patients With Genetically Confirmed Gorlin Syndrome From the HIT-MED CohortKatja Kloth, Denise Obrecht, Dominik Sturm, et al.
Pageof 52